Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest update is out from Aurobindo Pharma Ltd ( (IN:AUROPHARMA) ).
Aurobindo Pharma Ltd has announced the incorporation of a new wholly owned subsidiary, Eugia Pharma Chile SpA, in Chile through its stepdown subsidiary, Eugia Pharma B.V. This strategic move aims to expand Aurobindo’s pharmaceutical business in the Chilean market, enhancing its international footprint and potentially increasing its market share in the region. The incorporation involves a 100% cash subscription to the share capital, with no governmental or regulatory approvals required, indicating a streamlined expansion process.
More about Aurobindo Pharma Ltd
Aurobindo Pharma Ltd is a prominent player in the pharmaceutical industry, primarily engaged in the manufacturing and marketing of generic pharmaceuticals and active pharmaceutical ingredients. The company focuses on a wide range of therapeutic segments and operates globally, with a significant presence in various international markets.
Average Trading Volume: 59,508
Technical Sentiment Signal: Hold
Current Market Cap: 638.9B INR
See more data about AUROPHARMA stock on TipRanks’ Stock Analysis page.